Biological significance of the maximum standardized uptake values on positron emission tomography in non‐small cell lung cancer

T Takenaka, T Yano, K Ito, Y Morodomi… - Journal of surgical …, 2009 - Wiley Online Library
Abstract Background The 2‐[18F]‐fluoro‐2‐deoxy‐d‐glucose positron emission tomography
(FDG‐PET) has recently become an important non‐invasive tool for the diagnosis and …

A Pilot Study of [18F]Fluorodeoxyglucose Positron Emission Tomography Scans During and After Radiation-Based Therapy in Patients With Non–Small-Cell Lung …

FMS Kong, KA Frey, LE Quint, RKT Haken… - Journal of clinical …, 2007 - ascopubs.org
Purpose To study whether changes of [18F] fluorodeoxyglucose positron emission
tomography (FDG-PET) during treatment correlate with post-treatment responses in tumor …

[HTML][HTML] Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not …

RJ Downey, T Akhurst, M Gonen, B Park… - The Journal of thoracic …, 2007 - Elsevier
OBJECTIVES: Positron emission tomographic maximal standardized uptake value has been
shown to predict survival after resection of non–small cell lung cancer. The relative …

Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.

DA Sazon, SM Santiago, GW Soo Hoo… - American journal of …, 1996 - atsjournals.org
Glycolysis is increased in tumor tissues.[18F] fluoro-2-deoxy-D-glucose (FDG) is a glucose
analogue radiopharmaceutical used in positron emission tomography (PET) to trace glucose …

Value of whole-body FDG PET in management of lung cancer

K Higashi, I Matsunari, Y Ueda, R Ikeda, J Guo… - Annals of nuclear …, 2003 - Springer
Abstract 18 F-fluorodeoxyglucose (FDG) PET imaging provides physiologic and metabolic
information that characterizes lesions that are indeterminate by CT. FDG PET imaging is …

Prognostic value of [18F]FDG-PET imaging in small cell lung cancer

N Pandit, M Gonen, L Krug, SM Larson - European journal of nuclear …, 2003 - Springer
Positron emission tomography (PET) utilizing fluorine-18 fluorodeoxyglucose (FDG) has
been used in the evaluation of non-small cell lung cancer (NSCLC). Recently its use in the …

Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma

H Uehara, Y Tsutani, S Okumura, H Nakayama… - The Annals of Thoracic …, 2013 - Elsevier
Background This multicenter study aimed to validate the ability of 18 F-fluorodeoxyglucose
positron emission tomography/computed tomography (PET/CT) plus high-resolution …

[HTML][HTML] Positron emission tomography/computerized tomography in lung cancer

I Sahiner, GU Vural - Quantitative Imaging in Medicine and Surgery, 2014 - ncbi.nlm.nih.gov
Positron emission tomography (PET) using 2-(18F)-flouro-2-deoxy-D-glucose (FDG) has
emerged as a useful tool in the clinical work-up of lung cancer. This review article provides …

Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the …

R Takahashi, H Hirata, I Tachibana… - Clinical Cancer …, 2012 - AACR
Purpose: Positron emission tomography (PET) with [18F] fluorodeoxyglucose (FDG) is
increasingly used in early assessment of tumor response after chemotherapy. We …

Staging non-small cell lung cancer with whole-body PET

EM Marom, HP McAdams, JJ Erasmus, PC Goodman… - Radiology, 1999 - pubs.rsna.org
PURPOSE: To compare the accuracies of whole-body 2-[fluorine 18] fluoro-2-deoxy-d-
glucose (FDG) positron emission tomography (PET) and conventional imaging (thoracic …